Color-coded imaging of splenocyte-pancreatic cancer cell interactions in the tumor microenvironment.
In spite of advances in surgical and medical care, pancreatic cancer remains a leading cause of cancer-related death in the United States. An understanding of cancer-cell interactions with host cells is critical to our ability to develop effective antitumor therapeutics for pancreatic cancer. We report here a color-coded model system for imaging cancer cell interactions with host immune cells within the native pancreas. A human pancreatic cancer cell line engineered to express green fluorescent protein (GFP) in the nucleus and red fluorescent protein (RFP) (DsRed2) in the cytoplasm was orthotopically implanted into the pancreas of a nude mouse. After 10-14 days, red or green fluorescent splenocytes from immune-competent transgenic-mouse donors expressing RFP and GFP, respectively, were delivered systemically to the pancreatic cancer-bearing nude mice. Animals were imaged after splenocyte delivery using high-resolution intravital imaging systems. At 1 day after iv injection red- or green-fluorescent spleen cells were found distributed in lung, liver, spleen and pancreas. By 4 days after cell delivery, however, the immune cells could be clearly imaged surrounding the tumor cells within the pancreas as well as collecting within lymphatic tissues such as lymph nodes and spleen. With the high-resolution intravital imaging afforded by the Olympus IV100 and OV100 systems, the interactions of the dual-colored cancer cells and the red- or green-fluorescent spleen cells could be clearly imaged in this orthotopic pancreatic cancer model. This color-coded in vivo imaging technology offers a novel approach to imaging the interactions of cancer and immune cells in the tumor microenvironment (TME).
McElroy
Michele
M
Department of Surgery, University of California, San Diego, California, USA.
Kaushal
Sharmeela
S
Bouvet
Michael
M
Hoffman
Robert M
RM
D000818:Animals; D002450:Cell Communication; D003116:Color; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D021621:Imaging, Three-Dimensional / Q000379:methods*; D051379:Mice; D008819:Mice, Nude; D010190:Pancreatic Neoplasms / Q000473:pathology*; D013154:Spleen / Q000166:cytology*
D049452:Green Fluorescent Proteins
Cell Cycle. 2006 Aug;5(16):1886-901
16963837
Genes Dev. 1999 Jun 1;13(11):1382-97
10364156
Cancer Metastasis Rev. 2006 Dec;25(4):521-9
17186383
Cancer Metastasis Rev. 2008 Mar;27(1):11-8
18066650
Cancer Res. 2007 Dec 15;67(24):11687-95
18089798
Cancer Res. 2008 Apr 1;68(7):2085-93
18381413
Cell Cycle. 2006 Jan;5(2):191-7
16357534
Cancer Res. 2006 Jan 1;66(1):259-66
16397239
Nat Protoc. 2006;1(3):1429-38
17406431
Pancreas. 2004 Oct;29(3):179-87
15367883
Nat Cell Biol. 2006 Dec;8(12):1369-75
17128264
Nat Rev Cancer. 2005 Oct;5(10):796-806
16195751
Nat Cell Biol. 2000 Oct;2(10):737-44
11025665
Nature. 2004 Sep 23;431(7007):405-6
15385993
Br J Cancer. 2001 Nov 30;85(11):1655-63
11742483
Cancer Res. 2008 Feb 1;68(3):918-26
18245495
PLoS One. 2007 Oct 24;2(10):e1075
17957257
Q J Nucl Med Mol Imaging. 2005 Dec;49(4):361-6
16407819
Nat Rev Immunol. 2005 Oct;5(10):749-59
16175180
Cell. 2006 Jan 27;124(2):263-6
16439202
Gastroenterology. 2005 May;128(6):1626-41
15887155
Cell Cycle. 2007 Nov 1;6(21):2706-8
17912040
Cancer Res. 2007 Jun 1;67(11):5195-200
17545599
Nat Protoc. 2006;1(2):928-35
17406326
Genesis. 2004 Dec;40(4):241-6
15593332
Cell Cycle. 2006 Jun;5(11):1198-201
16760659
Gastroenterology. 2005 Apr;128(4):907-21
15825074
Surgery. 2007 May;141(5):610-8
17462460
Pancreas. 1995 Nov;11(4):345-9
8532650
Nat Protoc. 2006;1(2):775-82
17406307
Nat Med. 2006 Mar;12(3):354-60
16501571
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Cancer Cell. 2005 Mar;7(3):211-7
15766659